Skip to main
ADUS

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 56%
Hold 11%
Sell 11%
Strong Sell 0%

Bulls say

Addus HomeCare is expected to benefit from federal policy changes within the home care sector, including a possible repeal of the 80/20 Medicaid Access rule. The company's strong market position and favorable regulatory environment make it a strong investment with potential for improved census dynamics and potential acquisition activity, despite recent sector multiple compression. The company's recent cash flow and M&A transactions provide further support for its growth potential in both personal care and hospice services.

Bears say

Addus HomeCare is currently facing challenges in maintaining and growing its average billable census, with a 2% decline in the first quarter of 2026. The company also faces potential risks from changes in state and federal policies, as well as integration challenges from its recent acquisition of Gentiva. These factors could negatively impact growth and margins in the future. Furthermore, the company's dependence on its Personal Care segment for the majority of its revenue could limit its diversification and leave it vulnerable to any challenges or changes in that segment. Combined with the high level of competition in the in-home care industry, this could lead to decreased profitability and slower growth for Addus HomeCare.

Addus HomeCare (ADUS) has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 11% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 9 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Jun 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $132.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $132.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.